#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma metastatic Chronic graft versus host disease in skin MELAS syndrome Wiskott-Aldrich syndrome Squamous cell carcinoma of the oral cavity Round cell liposarcoma Friedreich's ataxia Loss of consciousness Hodgkin's disease Angelman's syndrome Kidney transplant rejection Tourette's disorder Antithrombin III deficiency Pyruvate kinase deficiency anaemia Plasma cell myeloma recurrent More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Hepatic angiosarcoma – Life with Disease Leukoencephalopathy – Diagnostics Behcet’s syndrome – Life with Disease Systemic mastocytosis – Diagnostics Lysosomal storage disorder – Treatment Leukoencephalopathy – Basic Information Factor IX deficiency – Basic Information Waldenstrom’s macroglobulinaemia refractory More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vancomycin Pentetic Acid GSKVX000000034798 Anakinra ATUMELNANT Romosozumab Reboxetine Pilocarpine Nitrate AMG 732 Ab-1002 METAMIZOLE SODIUM Seralutinib Mepivacaine Hydrochloride Afimetoran Besilate Dihydrate Elivaldogene Autotemcel Iph6501 Paroxetine Hydrochloride Ecoo1A Sym024 Gen3017 More therapies…

    Learn about Your Condition

    Endometrial cancer stage I Corneal graft failure Gastrointestinal disorder Malignant oligodendroglioma Multifocal motor neuropathy Urethral stenosis Multiple sclerosis relapse Dystonia Hyperthyroidism Hereditary angioedema Angiosarcoma Ocular myasthenia Aortic valve disease Alpha-1 antitrypsin deficiency Chondrocalcinosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of belatacept, tacrolimus and ciclosporin in heart transplant patients at risk of kidney failure

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Complications of transplanted heart
    Investigated Drugs:
    • Belatacept
    • Ciclosporin
    • Tacrolimus
    France

  • Study on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients

    Recruiting

    3 1
    Investigated Drugs:
    • Mexiletine Hydrochloride
    Belgium Denmark Germany Italy Spain

  • Comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children with chronic kidney disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency anaemia
    Investigated Drugs:
    • Ferumoxytol
    • Iron Sucrose
    Hungary Lithuania Poland

  • Study of Pembrolizumab for Patients with Mismatch Repair Deficient Uterine Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Pembrolizumab
    The Netherlands

  • Study on the Effects of Metformin in Patients with Cirrhosis and Portal Hypertension Already Treated with Carvedilol

    Recruiting

    2 1 1
    Investigated Drugs:
    • Metformin Embonate
    France

  • Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

    Recruiting

    3 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Furosemide Ph. Eur.
    Czechia Denmark Lithuania The Netherlands Sweden
Previous Page
1 … 358 359 360 361 362 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!